EMBO Rep 16:130–132īlázquez C, Chiarlone A, Sagredo O, Aguado T, Pazos MR, Resel E (2011) Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease. Oxford University Press, Oxford, p 142īraun A, Engel T, Aguilar-Pimentel JA, ZimmerA JT, Behrendt H (2011) Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.īrain 134:119–136īowker J (1997) The Oxford dictionary of world religions. Immunobiology 216(4):466–476īrooks JW, Pryce G, Bisogno T et al (2002) Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB (1)/CB (2) receptors. Eur J Pharmacol 439(1–3):83–92Ĭacciola G, Chianese R, Chioccarelli T, Ciaramella V, Fasano S, Pierantoni R et al (2010) Cannabinoids and reproduction: a lasting and intriguing history. Pharmaceuticals 3:3275–3323Ĭannabinoids GM (2003) Potential anticancer agents. Nat Rev Cancer 3:745–755Ĭarracedo A, Gironella M, Lorente M, Garcia S, Guzmán M, Velasco G, Iovanna JL (2006) Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress–related genes.
0 Comments
Leave a Reply. |